位于首都机场临空经济区的北京航空发动机维修有限公司将于今年底实现首台发动机进场，2026年初正式投入运营。作为中国内地唯一一家遄达系列发动机 大修厂，该公司注册资本1.9亿美元，填补了内地在遄达系列高推力航空发动机维修领域的空白，将带动临空区航空高级别维修、高端制造、航空服务及科 技研发等产业集聚，助力顺义航空航天产业高质量发展。 北京航空发动机维修有限公司外景。 英国罗尔斯·罗伊斯公司作为全球最主要的航空发动机供应商，目前为中国境内超500架宽体飞机提供发动机，占企业全球遄达发动机交付总量的20%。长期 以来，中国国际航空股份有限公司是罗尔斯·罗伊斯的重要客户，双方决定在北京成立合资企业北京航空发动机维修有限公司，各持股50%，旨在深化战略 合作。"十四五"期间，双方在2022中国国际服务贸易交易会上，共同签署了入区协议。 罗尔斯·罗伊斯将为大中华区航空公司客户提供本地化发动机大修服务。中国国际航空股份有限公司通过此合资企业完善其机务维修产业布局，并为国航机 队运行提供可靠的保障。 走进北京航空发动机维修有限公司，灰色调为主的建筑简约大气，工作人员正紧锣密鼓地忙碌着，为公司顺利投产做准备。"自2023年8月 ...

Group 1: Company Strategy and Vision - Rolls-Royce is positioning itself at the forefront of the energy transition, aiming to power artificial intelligence (AI) with nuclear reactors [1] - The CEO, Tufan Erginbilgic, believes that the company has the potential to become the highest-valued company in the UK through Small Modular Reactor (SMR) transactions [1][3] - The company has received government support to build the UK's first SMR, which led to a stock price increase of over 2% on the announcement day [3][4] Group 2: Market Potential and Demand - Supporters of nuclear energy argue that it can significantly aid countries in generating power, reducing emissions, and decreasing reliance on fossil fuels [3] - The global demand for SMRs is projected to reach 400 units by 2050, with each unit costing approximately $3 billion, indicating a potential market size exceeding $1 trillion [3][4] - Major tech companies, including Amazon and Google, are increasingly turning to nuclear energy to meet the rising energy demands of data centers [3][4] Group 3: Current Operations and Future Outlook - Rolls-Royce has signed agreements to build six SMRs in the Czech Republic and is developing three in the UK, with interest from tech giants like Google, Microsoft, and Meta [4] - The company’s current largest business remains aircraft engines, with a dominant position in supplying engines for wide-body aircraft like Boeing 787 and Airbus A350 [4] - The CEO expresses confidence that the company can surpass competitors like AstraZeneca and HSBC to become the most valuable company in the UK, driven by growth potential from existing and new businesses [7]